Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc... Show more
Fortive's third-quarter report matters because it tests whether the company's "Fortive Accelerated" strategy — a push into faster-growing, more recurring-revenue markets such as data centers, defense, and software — is translating into durable financial momentum. Since the July 2025 separation of its Precision Technologies business, Fortive has been repositioned around two segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Investors are watching closely to see whether accelerated core growth, expanding margins, and heavy share repurchases can sustain double-digit adjusted EPS growth, and whether the slower-growing healthcare segment can hold its own against the stronger industrial business.
For the third quarter of 2026, which ended October 2, 2026, Fortive reported revenue of $1,107.5 million, up 7.8% on a reported basis and 7.2% on a core basis compared with the prior-year period. GAAP diluted EPS from continuing operations was $0.57, up from $0.35 a year earlier. Adjusted diluted EPS was $0.77, a 13.2% increase over $0.68, and came in $0.06 above the analyst consensus of $0.71.
Adjusted EBITDA grew 9.5% to $338.8 million, with adjusted EBITDA margin expanding about 50 basis points to 30.6%. Free cash flow was $283.8 million in the quarter, and trailing twelve-month free cash flow exceeded $1 billion, with conversion on adjusted net income above 100%.
By segment, Intelligent Operating Solutions revenue rose 9.8% (9.1% core) to $767.1 million, while Advanced Healthcare Solutions revenue increased 3.7% (3.1% core) to $340.4 million. Management raised full-year 2026 adjusted EPS guidance to $3.10 to $3.14, up roughly 15% year over year at the midpoint.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. To put Fortive's results in a broader market context, consider using the AI Screener to compare FTV against peers and uncover similar opportunities.
Fortive shares closed at $61.62 on the reporting day, with the stock up roughly 4% over the prior three months and about 22% over the trailing twelve months. The market's initial read of the quarter leaned positive, reflecting a beat on adjusted EPS and revenue, sustained double-digit profit growth, and an upward revision to full-year guidance. Sentiment was tempered somewhat by the softer performance in Advanced Healthcare Solutions, where adjusted EBITDA declined about 4.8% year over year. Investors also noted that GAAP EPS came in below some analyst estimates, a reminder that non-GAAP adjustments — including amortization and a one-time tariff refund benefit — play a meaningful role in the headline adjusted figures.
Fortive enters the fourth quarter with raised full-year adjusted EPS guidance of $3.10 to $3.14, implying management's confidence that the momentum in Intelligent Operating Solutions can continue. Investors should watch whether core growth in that segment, led by Fluke, gas detection, and Facilities and Asset Lifecycle Solutions, remains in the high single digits or continues to accelerate.
Margin durability is another key factor. Adjusted gross margin dipped about 80 basis points year over year due to product mix, even as price-cost stayed positive. Monitoring whether pricing and productivity programs offset mix pressure will be important for assessing whether the 30.6% adjusted EBITDA margin is sustainable.
In healthcare, the focus will be on whether Advanced Healthcare Solutions can reaccelerate beyond its roughly 3% core growth. Finally, capital allocation remains central: Fortive deployed another $300 million toward share repurchases in the quarter, and investors will be watching how management balances buybacks, a modestly growing dividend, and potential bolt-on M&A (mergers and acquisitions) opportunities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
an operator of industrial units that manufacture testing and measurement equipment
Industry ElectronicEquipmentInstruments